{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:46:28Z","timestamp":1787240788209,"version":"build-2736575974"},"reference-count":42,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Graves' orbitopathy (GO) is associated with Graves' disease, in which anti-TSH receptor (TSHR) autoantibodies (thyroid-stimulating antibodies) increase cAMP causing hyperthyroidism. Excess adipogenesis and hyaluronan (HA) overproduction [HA synthase 2 (HAS2) is the major source] expand the orbital contents causing GO. TSHR activation participates in both processes but an anti-TSHR monoclonal without TSAB activity also increased HA, suggesting the involvement of other cascades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective and Patients Studied:<\/jats:title>\n                    <jats:p>We investigated using in vitro models in which preadipocytes\/fibroblasts from human orbital (n = 12) and sc (n = 10) adipose tissues were treated with IGF-I (to probe the pAkt pathway, recently identified as a positive regulator of HAS2), TSH, and\/or various inhibitors. Changes in HA during in vitro-induced adipogenesis were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome and Results:<\/jats:title>\n                    <jats:p>Adipogenesis in orbital preadipocytes was accompanied by significantly increased HAS2 transcripts and HA accumulation in contrast to sc cells in which differentiation significantly decreased HAS2 mRNA and secreted HA. Surprisingly, IGF-I alone did not increase HAS2 levels, despite significantly increasing the ratio of phosphorylated to total Akt; furthermore, an Akt inhibitor increased orbital (but not sc) HAS2 transcripts. A stimulatory effect of IGF-I on HAS2 transcripts was revealed by addition of rapamycin in sc but by a MAPK kinase inhibitor in orbital fibroblasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The results have several possible explanations including a phosphorylation-dependent repressor of HAS2 transcript accumulation, exclusively in the orbit. The difference in control of HAS2 expression allows the activation of one of the mechanisms underlying GO, adipogenesis, to be linked biologically with the second, HA overproduction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jc.2011-1299","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T21:43:10Z","timestamp":1323294190000},"page":"653-662","source":"Crossref","is-referenced-by-count":46,"title":["Adipose Tissue Depot-Specific Differences in the Regulation of Hyaluronan Production of Relevance to Graves' Orbitopathy"],"prefix":"10.1210","volume":"97","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[{"name":"Centre for Endocrine and Diabetes Sciences (L.Z., F.G.-J., D.A.R., C.M.D., M.L.), Cardiff CF14 4XN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Grennan-Jones","sequence":"additional","affiliation":[{"name":"Centre for Endocrine and Diabetes Sciences (L.Z., F.G.-J., D.A.R., C.M.D., M.L.), Cardiff CF14 4XN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Lane","sequence":"additional","affiliation":[{"name":"School of Medicine, Cardiff University, and Department of Ophthalmology (C.L.), Cardiff and Vale University Health Board, Heath Park, Cardiff CF14 4XN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Aled","family":"Rees","sequence":"additional","affiliation":[{"name":"Centre for Endocrine and Diabetes Sciences (L.Z., F.G.-J., D.A.R., C.M.D., M.L.), Cardiff CF14 4XN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin M.","family":"Dayan","sequence":"additional","affiliation":[{"name":"Centre for Endocrine and Diabetes Sciences (L.Z., F.G.-J., D.A.R., C.M.D., M.L.), Cardiff CF14 4XN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Ludgate","sequence":"additional","affiliation":[{"name":"Centre for Endocrine and Diabetes Sciences (L.Z., F.G.-J., D.A.R., C.M.D., M.L.), Cardiff CF14 4XN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071616355522300_B1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0029-1220935","article-title":"Current insights into the pathogenesis of Graves' orbitopathy.","volume":"41","author":"Eckstein","year":"2009","journal-title":"Horm Metab Res"},{"key":"2020071616355522300_B2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2249.2002.01792.x","article-title":"Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease.","volume":"127","author":"Ludgate","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2020071616355522300_B3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy.","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"2020071616355522300_B4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/105072502753600124","article-title":"Thyrotropin receptor expression in orbital adipose\/connective tissues from patients with thyroid-associated ophthalmopathy.","volume":"12","author":"Bahn","year":"2002","journal-title":"Thyroid"},{"key":"2020071616355522300_B5","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1210\/jcem.82.6.2003","article-title":"Thyrotropin receptor transcripts in human adipose tissue.","volume":"82","author":"Crisp","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616355522300_B6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1677\/jme.0.0300369","article-title":"Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo.","volume":"30","author":"Starkey","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"2020071616355522300_B7","first-page":"2557","article-title":"Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor.","volume":"84","author":"Valyasevi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616355522300_B8","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1167\/iovs.06-0596","article-title":"Biological effects of thyrotropin receptor activation on human orbital preadipocytes.","volume":"47","author":"Zhang","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020071616355522300_B9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/JOE-09-0099","article-title":"Gs\u03b1 signalling suppresses PPAR\u03b32 generation and inhibits 3T3L1 adipogenesis.","volume":"202","author":"Zhang","year":"2009","journal-title":"J Endocrinol"},{"key":"2020071616355522300_B10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JME-11-0006","article-title":"A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.","volume":"46","author":"Kumar","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"2020071616355522300_B11","doi-asserted-by":"crossref","first-page":"26447","DOI":"10.1074\/jbc.M109.003616","article-title":"Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction.","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"2020071616355522300_B12","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1210\/jcem.87.4.8411","article-title":"Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry.","volume":"87","author":"Metcalfe","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616355522300_B13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/thy.2010.0123","article-title":"Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.","volume":"21","author":"van Zeijl","year":"2011","journal-title":"Thyroid"},{"key":"2020071616355522300_B14","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(92)90024-Z","article-title":"Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor.","volume":"88","author":"Van Sande","year":"1992","journal-title":"Mol Cell Endocrinol"},{"key":"2020071616355522300_B15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/en.2008-0878","article-title":"Characterization of thyrotropin receptor antibody-induced signaling cascades.","volume":"150","author":"Morshed","year":"2009","journal-title":"Endocrinology"},{"key":"2020071616355522300_B16","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1210\/en.2010-0424","article-title":"Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.","volume":"151","author":"Morshed","year":"2010","journal-title":"Endocrinology"},{"key":"2020071616355522300_B17","doi-asserted-by":"crossref","first-page":"25085","DOI":"10.1074\/jbc.274.35.25085","article-title":"Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties.","volume":"274","author":"Itano","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071616355522300_B18","doi-asserted-by":"crossref","first-page":"22901","DOI":"10.1074\/jbc.M109.088435","article-title":"Methyl-\u03b2-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt.","volume":"285","author":"Kultti","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071616355522300_B19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/BC20080011","article-title":"Developmental origin of adipocytes: new insights into a pending question.","volume":"100","author":"Billon","year":"2008","journal-title":"Biol Cell"},{"key":"2020071616355522300_B20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.abb.2006.05.010","article-title":"Gene expression, synthesis and degradation of hyaluronan during differentiation of 3T3-L1 adipocytes.","volume":"452","author":"Allingham","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"2020071616355522300_B21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2002-021349","article-title":"Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.","volume":"88","author":"Krassas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616355522300_B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","article-title":"Restraining PI3K: mTOR signalling goes back to the membrane.","volume":"30","author":"Harrington","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"2020071616355522300_B23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1081\/NCN-120027815","article-title":"An improved total synthesis of triciribine: a tricyclic nucleoside with antineoplastic and antiviral properties.","volume":"23","author":"Porcari","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2020071616355522300_B24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(86)90698-7","article-title":"Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin.","volume":"1","author":"Hansson","year":"1986","journal-title":"Lancet"},{"key":"2020071616355522300_B25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/08916930310001603000","article-title":"The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation.","volume":"36","author":"Smith","year":"2003","journal-title":"Autoimmunity"},{"key":"2020071616355522300_B26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08916939309014643","article-title":"Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy.","volume":"16","author":"Weightman","year":"1993","journal-title":"Autoimmunity"},{"key":"2020071616355522300_B27","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/en.2005-1375","article-title":"Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease.","volume":"147","author":"Gianoukakis","year":"2006","journal-title":"Endocrinology"},{"key":"2020071616355522300_B28","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor.","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616355522300_B29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1530\/acta.0.1260541","article-title":"Effect of growth-factors on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts of Graves' ophthalmopathy in culture.","volume":"126","author":"Imai","year":"1992","journal-title":"Acta Endocrinol"},{"key":"2020071616355522300_B30","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1074\/jbc.R109.094003","article-title":"Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.","volume":"285","author":"Foster","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071616355522300_B31","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","article-title":"Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.","volume":"26","author":"Wan","year":"2007","journal-title":"Oncogene"},{"key":"2020071616355522300_B32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-2187-5-10","article-title":"Inhibition of PI3K\/AKT and MAPK\/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.","volume":"5","author":"Roy","year":"2010","journal-title":"J Mol Signal"},{"key":"2020071616355522300_B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/dbio.2002.0780","article-title":"Forkhead transcription factors: key players in development and metabolism.","volume":"250","author":"Carlsson","year":"2002","journal-title":"Dev Biol"},{"key":"2020071616355522300_B34","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1210\/en.2003-0438","article-title":"Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context.","volume":"144","author":"Fuhrer","year":"2003","journal-title":"Endocrinology"},{"key":"2020071616355522300_B35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors.","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem J"},{"key":"2020071616355522300_B36","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","article-title":"Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res"},{"key":"2020071616355522300_B37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.archoralbio.2007.07.011","article-title":"Regulation of HAS expression in human synovial lining cells of TMJ by IL-1\u03b2.","volume":"53","author":"Li","year":"2008","journal-title":"Arch Oral Biol"},{"key":"2020071616355522300_B38","doi-asserted-by":"crossref","first-page":"18270","DOI":"10.1074\/jbc.M109.012492","article-title":"Regulation of the hyaluronan synthase 2 gene by convergence in cyclic AMP response element-binding protein and retinoid acid receptor signaling.","volume":"284","author":"Makkonen","year":"2009","journal-title":"J Biol Chem"},{"key":"2020071616355522300_B39","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.1074\/jbc.M607871200","article-title":"Integration of the activation of the human hyaluronan synthase 2 gene promoter by common cofactors of the transcription factors retinoic acid receptor and nuclear factor \u03baB.","volume":"282","author":"Saavalainen","year":"2007","journal-title":"J Biol Chem"},{"key":"2020071616355522300_B40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1074\/jbc.M109.038620","article-title":"Increased cAMP levels modulate transforming growth factor-\u03b2\/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions.","volume":"285","author":"Schiller","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071616355522300_B41","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1167\/iovs.08-2443","article-title":"Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.","volume":"50","author":"van Steensel","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020071616355522300_B42","doi-asserted-by":"crossref","first-page":"15794","DOI":"10.1074\/jbc.M109.074534","article-title":"Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 via DP1 activation: implications for thyroid eye disease.","volume":"285","author":"Guo","year":"2010","journal-title":"J Biol Chem"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/2\/653\/10413793\/jcem0653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/2\/653\/10413793\/jcem0653.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T23:20:50Z","timestamp":1594941650000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/2\/653\/2836465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2011-1299","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,1]]}}}